⌘K

Login Start Free

Home/Filings/4/0001250853-14-000026

4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001250853-14-000026

$SLSCIK 0001390478operating

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:14 PM ET

Size

16.9 KB

Accession

0001250853-14-000026

Insider Transaction Report

Form 4

Period: 2014-01-17

Galena Biopharma, Inc.GALE

KRIEGSMAN STEVEN A

Director

Transactions

Exercise/Conversion
Common Stock
2014-01-22$1.18/sh+200,000$236,000→ 205,000 total
Sale
Common Stock
2014-01-22$6.13/sh−250,000$1,532,500→ 5,000 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-17−200,000→ 0 total
Exercise: $0.85From: 2011-09-27Exp: 2021-09-27→ Common Stock (200,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-01-22−50,000→ 0 total
Exercise: $0.72From: 2013-01-12Exp: 2022-01-12→ Common Stock (50,000 underlying)
Sale
Common Stock
2014-01-17$7.00/sh−200,000$1,400,000→ 5,000 total
Exercise/Conversion
Common Stock
2014-01-17$0.85/sh+200,000$170,000→ 205,000 total
Exercise/Conversion
Common Stock
2014-01-22$0.72/sh+50,000$36,000→ 255,000 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-22−200,000→ 0 total
Exercise: $1.18From: 2011-03-25Exp: 2021-03-24→ Common Stock (200,000 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001390478

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 9:14 PM ET
Size: 16.9 KB

View on SEC.gov